Results

Total Results: 330 records

Showing results for "sedation".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - people with primary depression �� Severe anaphylactic or anaphylactoid reactions �� Possible profound sedation
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
    June 15, 2010 - Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3.pdf
    May 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … THC to CBD ratio) may be associated with moderate improvement in pain severity and increased risk of sedationSedation for comparable THC to CBD ratio versus placebo (short-term, 4 weeks to 6 months followup) … Sedation for high THC versus placebo (short-term, 4 weeks to 6 months followup) Abbreviations: CI … Placebo Sedation 3 RCTs (N=335)9- 11 Moderate Direct Consistent Imprecise Unknown Moderate effect
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … THC to CBD ratio) may be associated with moderate improvement in pain severity and increased risk of sedationSedation for comparable THC to CBD ratio versus placebo (short-term, 4 weeks to 6 months followup) … Sedation for high THC versus placebo (short-term, 4 weeks to 6 months followup) Abbreviations: CI … Placebo Sedation 3 RCTs (N=335)9- 11 Moderate Direct Consistent Imprecise Unknown Moderate effect
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
    November 27, 2012 - Commentator & Affiliation Section Comment Response Peer Reviewer #4 Structured abstract "The risk of sedation … the following information from the abstract for both metoclopromide and neuroleptics: "The risk of sedation … The risk of sedation is from the side effects section under both agents, and the reference to the 10 … The most common side effects were skin and local reactions, sedation, digestive problems, nausea or … reestablish the homeostasis needed to abort an attack. no one has looked to low dose ketamine followed by sedation
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_executive.pdf
    April 01, 2013 - In one RCT, dosing of sedation (light vs. deep) in critically ill patients did not affect posttraumatic … Robbery victims29 PTSD symptom severity Inconclusive, single trial (N=77) Insufficient Pharmacological sedation … trial (N=236), inconsistent findings at different assessment intervals Insufficient Pharmacological sedation … One randomized open-label trial considered comparative risk of harms from light versus deep sedation … Randomized trial of light versus deep sedation on mental health after critical illness.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
    July 01, 2012 - Peer Reviewer 3 Introduction I recommend adding that NPPV does not require moderate sedation (instead … of only “deep” sedation) Page ES-2, line 26: add “moderate and/or” just prior to “…deep sedation” … Page 3, line 39: add “moderate and/or” just prior to “…deep sedation” The text has been modified to … specify “moderate and/or deep sedation.”
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e1.xlsx
    March 13, 2023 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis
  10. effectivehealthcare.ahrq.gov/products/wireless-motility-capsule/research-protocol
    March 14, 2012 - testing procedure, a manometry catheter is inserted into the pyloric channel with endoscopic guidance and sedation … motility capsule include that it is wireless and painless, can be used in an office setting without sedation … The catheter is left in place in some cases for up to 24 hours, and recordings are obtained after sedation … would capture the number of hours without anything by mouth before the procedure and the method of sedation
  11. effectivehealthcare.ahrq.gov/health-topics/anesthesia
  12. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-surveillance-report-3.pdf
    May 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … THC to CBD ratio) may be associated with moderate improvement in pain severity and increased risk of sedationSedation for comparable THC to CBD ratio versus placebo (short-term, 4 weeks to 6 months followup) … Sedation for high THC versus placebo (short-term, 4 weeks to 6 months followup) Abbreviations: CI … Placebo Sedation 3 RCTs (N=335)9- 11 Moderate Direct Consistent Imprecise Unknown Moderate effect
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-nerve-block-key-questions.pdf
    May 09, 2019 - Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast
  14. effectivehealthcare.ahrq.gov/sites/default/files/prehospital-airway-management-draft-appendix-f.xlsx
    June 22, 2020 - assisted intubation RSI + sedation video 22049 Success First Pass Success As Treated, airway attempted … assisted intubation RSI + sedation video 470 Success First Pass Success As Treated, airway attempted … assisted intubation RSI + sedation video 22519 Success First Pass Success As treated, airway attempted … assisted intubation RSI + sedation video 6573 Success First Pass Success As treated, airway attempted … assisted intubation RSI + sedation video 1898 Success First Pass Success As treated, airway attempted
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
    January 01, 2007 - In the CATIE trial, risperidone, quetiapine, and olanzapine were each more likely to cause sedation than … Odds were also higher for gastrointestinal problems, increased salivation, fatigue, EPS, and sedation … Compared to placebo, all atypicals were associated with sedation in multiple pooled analyses for all
  16. effectivehealthcare.ahrq.gov/products/antipsychotics-children/research-protocol
    June 04, 2010 - Side effects vary among the various medications, but common side effects include dry mouth, sedation, … effects Weight gain (e.g., using Body Mass Index (BMI) growth charts) Agitation Constipation Sedation … events: extrapyramidal effects, weight gain (e.g., using BMI growth charts), agitation, constipation, sedation
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
    March 14, 2012 - procedure, a manometry catheter is inserted into the pyloric channel with endoscopic guidance and sedation … motility capsule include that it is wireless and painless, can be used in an office setting without sedation … The catheter is left in place in some cases for up to 24 hours, and recordings are obtained after sedation … would capture the number of hours without anything by mouth before the procedure and the method of sedation

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: